Pacific Biosciences of California, Inc. splits its revenue into 3 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Consumables at $20.8 million, 51% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
161
|
41
|
39
|
37
|
45
|
38
|
40
|
37
|
—
|
| Consumables |
84
+6.6%
share 52.3%
|
21
-2.1%
share 51.3%
|
20
+6.2%
share 51.6%
|
22
+8.5%
share 58.7%
|
22
+15.0%
share 48.4%
|
21
share 55.4%
|
19
share 47.6%
|
20
share 54.1%
|
19
|
| Instrument |
53
+2.5%
share 32.9%
|
13
+16.4%
share 32.5%
|
13
-9.3%
share 32.9%
|
10
-11.8%
share 26.1%
|
17
+13.4%
share 38.8%
|
11
share 29.4%
|
14
share 35.6%
|
11
share 29.7%
|
15
|
| Service And Other |
24
+1.1%
share 14.8%
|
7
+12.3%
share 16.2%
|
6
-9.4%
share 15.5%
|
6
-6.6%
share 15.2%
|
6
+10.8%
share 12.7%
|
6
share 15.2%
|
7
share 16.8%
|
6
share 16.3%
|
5
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- PACB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Menlo Park, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1299130
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC (until Feb 5, 2013); NANOFLUIDICS INC (until Jul 28, 2004)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.